Brookfield weighs $7.4bn bid for Spain’s Grifols
Canadian private equity firm Brookfield is reportedly considering a €7bn ($7.4bn) takeover bid for Spanish pharmaceutical company Grifols and is completing due diligence on the plasma-based drugmaker, according to a report by El Confidencial.

